Literature DB >> 30390986

Vascular Surgery and Geriatric Patients.

Pegge M Halandras1.   

Abstract

As the population ages, surgical decision-making in vascular surgery has become more complex. Older patients may not have been offered vascular surgical intervention in the past because of prohibitive physiologic demands and poor health. Patients now have more aggressive management of vascular risk factors with medications, such as statin therapy, and less invasive endovascular or hybrid treatment options. Outcomes in elderly patients may not be comparable with younger patients for entities such as aortic aneurysm repair, carotid endarterectomy, or lower extremity revascularization. Despite this, desirable outcomes can be successfully achieved and should be offered to carefully selected elderly individuals.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic aneurysm; Carotid artery endarterectomy; Critical limb ischemia; Delirium; End stage renal disease; Frailty

Mesh:

Year:  2018        PMID: 30390986     DOI: 10.1016/j.cger.2018.08.008

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  3 in total

1.  Transition in Frailty State Among Elderly Patients After Vascular Surgery.

Authors:  Louise B D Banning; Linda Visser; Clark J Zeebregts; Barbara L van Leeuwen; Mostafa El Moumni; Robert A Pol
Journal:  World J Surg       Date:  2020-10       Impact factor: 3.352

Review 2.  [Innovative geriatric concepts for vascular medicine and vascular surgery].

Authors:  Björn Maassen; Konstantinos Chondros; Leo Cornelius Bollheimer
Journal:  Gefasschirurgie       Date:  2021-08-18

3.  Cerebral and Systemic Stress Parameters in Correlation with Jugulo-Arterial CO2 Gap as a Marker of Cerebral Perfusion during Carotid Endarterectomy.

Authors:  Zoltán Kovács-Ábrahám; Timea Aczél; Gábor Jancsó; Zoltán Horváth-Szalai; Lajos Nagy; Ildikó Tóth; Bálint Nagy; Tihamér Molnár; Péter Szabó
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.